Pharmaco-metabolomics

Pharmacometabolomics/Pharmacometabonomics is used to determibe the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmacometabolomics is still in its infancy because most pharmacometabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors such as diets, ages, drug intake and gut microbiota with drug responses or disease susceptibility to study and minimize the metabolic biases.

 

    Related Conference of Pharmaco-metabolomics

    October 21-22, 2020

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 10-11, 2020

    2nd Pathology and Infectious Disease Conference

    Dubai, UAE
    March 18-19, 2021

    12th Tissue Repair and Regeneration Congress

    Abu Dhabi, UAE
    March 28-29, 2021

    11th Glycobiology World Congress

    Vienna, Austria
    June 11-12, 2021

    25th Global Congress on Biotechnology

    Berlin, Germany
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland

    Pharmaco-metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in